Oppilotech Company

Developing the next generation of antibiotics with novel mechanisms of action.

Headquarters: London, England, United Kingdom
Industry: Medical BioTech
Investors Number: 3.0
Funding Status: Seed
Last Funding Type: Grant
Founded Date: 2014-01-01
Total Funding: 146357.0
Last Funding Date: 2018-07-12